OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Transarterial chemoembolization (TACE) combined with apatinib versus TACE combined with sorafenib in advanced hepatocellular carcinoma patients: a multicenter retrospective study
Zhiyu Qiu, Lujun Shen, Yiquan Jiang, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 4, pp. 283-283
Open Access | Times Cited: 15
Zhiyu Qiu, Lujun Shen, Yiquan Jiang, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 4, pp. 283-283
Open Access | Times Cited: 15
Showing 15 citing articles:
Role of Transarterial Chemoembolization in the Era of Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Combination Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Propensity Score Matched Analysis
Jin-Xing Zhang, Hong-Jin Hua, Yuan Cheng, et al.
Academic Radiology (2023) Vol. 31, Iss. 4, pp. 1304-1311
Closed Access | Times Cited: 11
Jin-Xing Zhang, Hong-Jin Hua, Yuan Cheng, et al.
Academic Radiology (2023) Vol. 31, Iss. 4, pp. 1304-1311
Closed Access | Times Cited: 11
Surgical resection versus thermal ablation: comparison of sequential options after successful TACE downstaging therapy for unresectable hepatocellular carcinoma
Chao An, Songsong Wu, Mengxuan Zuo, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Chao An, Songsong Wu, Mengxuan Zuo, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A comparative retrospective study
Jinxing Zhang, Yu‐Xing Chen, Chun‐Gao Zhou, et al.
Hepatology Research (2022) Vol. 52, Iss. 9, pp. 794-803
Closed Access | Times Cited: 15
Jinxing Zhang, Yu‐Xing Chen, Chun‐Gao Zhou, et al.
Hepatology Research (2022) Vol. 52, Iss. 9, pp. 794-803
Closed Access | Times Cited: 15
Efficacy of Transarterial Chemoembolization Combined with Molecular Targeted Agents for Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis
Zhenzhen Zhang, Yanfang Wu, Tang‐Hui Zheng, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3710-3710
Open Access | Times Cited: 14
Zhenzhen Zhang, Yanfang Wu, Tang‐Hui Zheng, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3710-3710
Open Access | Times Cited: 14
What Is the Most Suitable Agent Combined With Apatinib for Transarterial Chemoembolization Treatment in Advanced Hepatocellular Carcinoma Patients? A Systematic Review and Network Meta-analysis
Fuhai Hui, Chang Xu, Xiangbo Xu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Fuhai Hui, Chang Xu, Xiangbo Xu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Transcatheter arterial chemoembolization of apatinib and camrelizumab (SHR1210) against liver metastasis from hepatic neuroendocrine tumor: a case report
Ruobing Qi, Wenhua Yang, Sixian Zhu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Ruobing Qi, Wenhua Yang, Sixian Zhu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Comparative efficacy and safety of molecular targeted agents combined with transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a network meta-analysis
Jiaye Long, Baoxiang Chen, Zhaohui Liu
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Jiaye Long, Baoxiang Chen, Zhaohui Liu
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Efficacy and safety of transcatheter arterial chemoembolization-lenvatinib sequential therapy for patients with unresectable hepatocellular carcinoma: a single-arm clinical study
Ruiqing Chen, Lingbing Li, Li Ye, et al.
Journal of Gastrointestinal Oncology (2022) Vol. 13, Iss. 3, pp. 1367-1375
Open Access | Times Cited: 5
Ruiqing Chen, Lingbing Li, Li Ye, et al.
Journal of Gastrointestinal Oncology (2022) Vol. 13, Iss. 3, pp. 1367-1375
Open Access | Times Cited: 5
Efficacy and Safety of the Arsenic Trioxide/Lipiodol Emulsion in the Transcatheter Arterial Chemoembolization Combined with Apatinib in the Treatment of Advanced Hepatocellular Carcinoma
Zhaonan Li, Quanjing Chen, Wenguang Zhang, et al.
Canadian Journal of Gastroenterology and Hepatology (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 5
Zhaonan Li, Quanjing Chen, Wenguang Zhang, et al.
Canadian Journal of Gastroenterology and Hepatology (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 5
Drug-eluting bead transarterial chemoembolization followed by apatinib is effective and safe in treating hepatocellular carcinoma patients with BCLC stage C
Shuguang Ju, Wenhui Wang, Pengfei Chen, et al.
Clinics and Research in Hepatology and Gastroenterology (2022) Vol. 46, Iss. 3, pp. 101859-101859
Closed Access | Times Cited: 3
Shuguang Ju, Wenhui Wang, Pengfei Chen, et al.
Clinics and Research in Hepatology and Gastroenterology (2022) Vol. 46, Iss. 3, pp. 101859-101859
Closed Access | Times Cited: 3
Predicting Outcome in Combination Treatment of TACE and Camrelizumab for Advanced Hepatocellular carcinoma: Tumor Hypervascularity and Reactive Cutaneous Capillary Endothelial Proliferation
Yin Liang, Kai‐Cai Liu, Wei‐Fu Lv, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 3421-3429
Open Access | Times Cited: 3
Yin Liang, Kai‐Cai Liu, Wei‐Fu Lv, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 3421-3429
Open Access | Times Cited: 3
The long-term efficacy and safety of apatinib are inferior to sorafenib in the first-line treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis
Dailong Li, Chunzhen Zhang, Kui Yang, et al.
Medicine (2024) Vol. 103, Iss. 3, pp. e36865-e36865
Open Access
Dailong Li, Chunzhen Zhang, Kui Yang, et al.
Medicine (2024) Vol. 103, Iss. 3, pp. e36865-e36865
Open Access
Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study
Tao Ouyang, Junxia Liu, Chengyang Shi, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 1459-1471
Open Access | Times Cited: 2
Tao Ouyang, Junxia Liu, Chengyang Shi, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 1459-1471
Open Access | Times Cited: 2
Clinical Research Progress of Apatinib in the Treatment of Hepatocellular Carcinoma
源 冯
Advances in Clinical Medicine (2021) Vol. 11, Iss. 12, pp. 6195-6200
Closed Access | Times Cited: 1
源 冯
Advances in Clinical Medicine (2021) Vol. 11, Iss. 12, pp. 6195-6200
Closed Access | Times Cited: 1
Apatinib plus drug-eluting bead transarterial chemoembolization as bridging therapy to surgical resection displays an acceptable efficacy and safety profile in hepatocellular carcinoma patients
Jingwei Yan, Yumei Sun, Daguang Fan, et al.
Indian Journal of Cancer (2023) Vol. 60, Iss. 4, pp. 562-569
Closed Access
Jingwei Yan, Yumei Sun, Daguang Fan, et al.
Indian Journal of Cancer (2023) Vol. 60, Iss. 4, pp. 562-569
Closed Access
